Sabra Health Care Reit earnings were $65.4M for the trailing 12 months ending Jun 30, 2026, with -67.9% growth year over year. The latest SBRA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$25.2M, down 161.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SBRA reported annual earnings of $155.6M, with 22.8% growth. The next SBRA earnings date is Nov 4, 2026.
SBRA past earnings growth
How has SBRA's earnings growth performed historically?
Sabra Health Care Reit Earnings Reports & History FAQ
What were Sabra Health Care Reit's earnings last quarter?
On SBRA's earnings call on Aug 3, 2026, Sabra Health Care Reit (NASDAQ: SBRA) reported Q2 2026 earnings per share (EPS) of -$0.10, up 135.71% year over year. Total SBRA earnings for the quarter were -$25.20 million. In the same quarter last year, Sabra Health Care Reit's earnings per share (EPS) was $0.28.
The next SBRA earnings date is Nov 4, 2026. Add SBRA to your watchlist to be reminded of Sabra Health Care Reit's next earnings date.
Is Sabra Health Care Reit profitable or losing money?
As of the last Sabra Health Care Reit earnings report, Sabra Health Care Reit is currently profitable. Sabra Health Care Reit's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $65.44 million, a 64.11% decrease year over year.
What was SBRA's earnings growth in the past year?
As of Sabra Health Care Reit's earnings date in Aug 3, 2026, Sabra Health Care Reit's earnings has grown -67.95% year over year. This is 94.45 percentage points lower than the US REIT - Healthcare Facilities industry earnings growth rate of 26.5%. SBRA earnings in the past year totalled $65.44 million.
What are Sabra Health Care Reit's earnings expectations?
The current EPS estimate for Sabra Health Care Reit's earnings report in Nov 4, 2026 is $0.39.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.